China's Strategic Leap into Brain-Computer Interface Technology

China is advancing rapidly in brain-computer interface (BCI) technology, aiming to implement practical products in three to five years. In its new strategic plan, Beijing prioritizes BCIs alongside sectors like quantum and AI. The move seeks to compete with U.S. firms, emphasizing clinical and industrial integration.

China could soon make significant strides in brain-computer interface (BCI) technology, potentially bringing it into public use within three to five years, according to a leading expert. The nation's new five-year plan marks BCIs as a core industry, joining other sectors like quantum, embodied AI, 6G, and nuclear fusion.

Yao Dezhong, Director of the Sichuan Institute of Brain Science, shared that new policies wouldn't create immediate changes but foresee the gradual public application of BCI products. With a development strategy aiming for breakthroughs by 2027, China is pushing to match U.S. advancements while promoting BCI human trials, anticipating enrollment of over 50 patients nationwide this year.

Notable trials have enabled partially paralyzed individuals to regain mobility using robotic devices. The government is integrating BCI treatments with national medical insurance as the market is projected to soar to 5.58 billion yuan by 2027. China's abundant talent and cost-effective industry aim to bridge gaps between research, clinical use, and the global race.